## COPAD – Low risk (Group A)

**Cyclophosphamide (CPM)**
-	Route: IV
-	Dosage: 250 mg/m2/dose, every 12 hours (500 mg/m2/day)
-   Dilute with 0.9% NaCl to a target concentration of < 20 mg/mL, administer via IV infusion over 1 hour
-   If the dosage is  > 1800 mg/m 2 , the infusion should last 4 – 6 hours
-	Used on Days 1 to 3
-	Caution: The first dose should be given on day 1 prior to the start of the doxorubicin infusion which should be interrupted to give subsequent doses of cyclophosphamide

**VinCRIStine (O)**
-	Route: IV
-	Dosage: 2 mg/m2/dose
-   Dilute with 10ml of 0.9% NaCl, IV infusion at 60ml/h
-	Used on Day 1 and Day 6
-	Caution: Maximum dose: 2 mg

**Prednisolone (P)**
-	Route: PO 
-	Dosage: 60mg/m2/day in 2 divided doses
-	Used in days 1 to 5, then reduced to zero over 3 days 
-	Caution: You may stop Prednisolone if tumour lysis cannot be controlled

**Doxorubicin (A)**
-	Route: IV Push/infusion over 6h
-	Dosage: 60 mg/m²/dose
-   Dilute with 50ml of 0.9% NaCl, IV infusion at 50ml/h
-	Used on Day 1, after first dose of IV cyclophosphamide completely

**G-CSF**
-	Route: subcutaneously
-	Dosage: 5 mcg/kg/day
-	Used on days 7 to 21. G-CSF should be discontinued when the post nadir ANC reaches 3000/mm3, even if prior to day 21. G-CSF should have been discontinued at least 48 hours prior the second COPAD course.
